{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:16:05Z","timestamp":1793463365359,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Neuroendocrine carcinomas (NECs) of the colon are among the rarest types of colorectal cancers. Among these, large cell type neuroendocrine carcinoma (LCNEC) is particularly rare. Colorectal NEC is an aggressive disease, and there are few reports of long-term survivors. Here, we report a case of LCNEC accompanied by disseminated peritoneal leiomyomatosis that was difficult to diagnose.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>The case involves a 62-year-old female found to be positive for fecal occult blood by medical examination. An endoscopy revealed a tumor in the ascending colon, and the biopsy revealed poorly differentiated cancer. Abnormal FDG accumulation with peritoneal thickening was visible on 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET) and suspected to be peritoneal dissemination. Laparoscopic ileocecal resection was performed for the tumor of the ascending colon with abdominal wall invasion. At that time, numerous intra-abdominal nodules were observed, indicating peritoneal dissemination. The pathological diagnosis of the primary lesion was LCNEC, and the patient requested to undergo total peritoneal resection. After one course of chemotherapy with irinotecan plus cisplatin, she underwent total peritoneal resection, uterine annex resection, left inguinal lymph node resection, and intra-abdominal hyperthermic intraperitoneal chemotherapy with mitomycin C. Because a postoperative pathological examination revealed that the intra-abdominal nodules were leiomyomas, we diagnosed the patient with disseminated peritoneal leiomyomatosis. The left inguinal lymph node was diagnosed with a metastatic tumor. In summary, the final diagnosis was LCNEC in the ascending colon with inguinal lymph node metastasis. Postoperative chemotherapy has been administered to date. She is currently 18\u00a0months post-primary surgery and 15\u00a0months post-peritonectomy without apparent recurrence or metastatic findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We experienced a case of Stage IVa colorectal LCNEC accompanied by disseminated peritoneal leiomyomatosis. Although the prognosis is generally poor, multidisciplinary treatment for advanced colorectal LCNEC may result in a favorable outcome for some patients. If peritoneal dissemination is suspected during operation, sampling of the nodule to confirm the pathological diagnosis is advisable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-020-01069-4","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T11:23:52Z","timestamp":1607513032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A case of colorectal large cell neuroendocrine carcinoma accompanied by disseminated peritoneal leiomyomatosis"],"prefix":"10.1186","volume":"6","author":[{"given":"Kunihiko","family":"Suga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chika","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuya","family":"Osone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhisa","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Yokobori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shirabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10350-003-0038-1","volume":"47","author":"PE Bernick","year":"2004","unstructured":"Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi W, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47:163\u20139.","journal-title":"Dis Colon Rectum"},{"key":"1069_CR2","doi-asserted-by":"publisher","first-page":"B268","DOI":"10.1111\/j.1440-1673.2007.01776.x","volume":"51","author":"M Demir","year":"2007","unstructured":"Demir M. Disseminated peritoneal leiomyomatosis: magnetic resonance imaging and differential diagnosis. Australas Radiol. 2007;51:B268\u201371.","journal-title":"Australas Radiol"},{"key":"1069_CR3","volume-title":"Classification of neuroendocrine neoplasms of the digestive system. WHO Classification of Tumours Digestive System Tumours","author":"D Klimstra","year":"2019","unstructured":"Klimstra D, Kl\u00f6ppel G, Larosasalas B. Classification of neuroendocrine neoplasms of the digestive system. WHO Classification of Tumours Digestive System Tumours. Lyon: Board The WHO Classification of Tumours Editorial: IARC Press; 2019."},{"key":"1069_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1440-1827.2005.01864.x","volume":"55","author":"T Kato","year":"2005","unstructured":"Kato T, Terashima T, Tomida S, Yamaguchi T, Kawamura H, Kimura N, et al. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon. Pathol Int. 2005;55:524\u20139.","journal-title":"Pathol Int"},{"key":"1069_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5009\/gnl.2010.4.1.122","volume":"4","author":"JS Park","year":"2010","unstructured":"Park JS, Kim L, Kim CH, Bang BW, Lee DH, Jeong S, et al. Synchronous large-cell neuroendocrine carcinoma and adenocarcinoma of the colon. Gut Liver. 2010;4:122\u20135.","journal-title":"Gut Liver"},{"key":"1069_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3393\/jksc.2011.27.3.157","volume":"27","author":"YN Kim","year":"2011","unstructured":"Kim YN, Park HS, Jang KY, Moon WS, Lee DG, Lee H, et al. Concurrent large cell neuroendocrine carcinoma and adenocarcinoma of the ascending colon: a case report. J Korean Soc Coloproctol. 2011;27:157\u201361.","journal-title":"J Korean Soc Coloproctol"},{"key":"1069_CR7","first-page":"250","volume":"2","author":"MR Pascarella","year":"2011","unstructured":"Pascarella MR, McCloskey D, Jenab-Wolcott J, Vala M, Rovito M, McHugh J. Large cell neuroendocrine carcinoma of the colon: a rare and aggressive tumor. J Gastrointest Oncol. 2011;2:250\u20133.","journal-title":"J Gastrointest Oncol"},{"key":"1069_CR8","first-page":"3377","volume":"32","author":"Z Juki\u0107","year":"2012","unstructured":"Juki\u0107 Z, Limani R, Luci LG, Niki\u0107 V, Miji\u0107 A, Tomas D, et al. hGH and GHR expression in large cell neuroendocrine carcinoma of the colon and rectum. Anticancer Res. 2012;32:3377\u201381.","journal-title":"Anticancer Res"},{"key":"1069_CR9","first-page":"386379","volume":"2014","author":"V Minocha","year":"2014","unstructured":"Minocha V, Shuja S, Ali R, Eid E. Large cell neuroendocrine carcinoma of the rectum presenting with extensive metastatic disease. Case Rep Oncol Med. 2014;2014:386379.","journal-title":"Case Rep Oncol Med"},{"key":"1069_CR10","first-page":"5177","volume":"7","author":"F Xu","year":"2014","unstructured":"Xu F, Feng GS, Wang ZJ, Zhang KN. Synchronous double cancers of colonic large cell neuroendocrine carcinoma and gastric squamous-cell carcinoma: a case report and review of literature. Int J Clin Exp Pathol. 2014;7:5177\u201380.","journal-title":"Int J Clin Exp Pathol"},{"key":"1069_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3393\/ac.2018.02.27","volume":"34","author":"JJ Kim","year":"2018","unstructured":"Kim JJ, Park SS, Lee TG, Lee HC, Lee SJ. Large cell neuroendocrine carcinoma of the colon with carcinomatosis peritonei. Ann Coloproctol. 2018;34:222\u20135.","journal-title":"Ann Coloproctol"},{"key":"1069_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/his.13875","volume":"75","author":"R Chetty","year":"2019","unstructured":"Chetty R, Capo-Chichi JM, Serra S. Colorectal large-cell neuroendocrine carcinoma with lymphoid stroma: further evidence confirming a unique subtype associated with MLH1\/PMS2 loss, BRAF mutation, Epstein-Barr virus negativity, and the possibility of a better prognosis. Histopathology. 2019;75:247\u201353.","journal-title":"Histopathology"},{"key":"1069_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/PAS.0b013e318242e21c","volume":"36","author":"S La Rosa","year":"2012","unstructured":"La Rosa S, Marando A, Furlan D, Sahnane N, Capella C. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers. Am J Surg Pathol. 2012;36:601\u201311.","journal-title":"Am J Surg Pathol"},{"key":"1069_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1\u201342.","journal-title":"Int J Clin Oncol"},{"key":"1069_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000274487","volume":"69","author":"A Al-Talib","year":"2010","unstructured":"Al-Talib A, Tulandi T. Pathophysiology and possible iatrogenic cause of leiomyomatosis peritonealis disseminata. Gynecol Obstet Invest. 2010;69:239\u201344.","journal-title":"Gynecol Obstet Invest"},{"key":"1069_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00404-007-0536-9","volume":"278","author":"S Kumar","year":"2008","unstructured":"Kumar S, Sharma JB, Verma D, Gupta P, Roy KK, Malhotra N. Disseminated peritoneal leiomyomatosis: an unusual complication of laparoscopic myomectomy. Arch Gynecol Obstet. 2008;278:93\u20135.","journal-title":"Arch Gynecol Obstet"},{"key":"1069_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40792-019-0690-x","volume":"5","author":"K Akamine","year":"2019","unstructured":"Akamine K, Kadono J, Otsuka H, Ueno K, Shimizu T, Nagata Y, et al. Gastrointestinal stromal tumor coexisting with disseminated peritoneal leiomyomatosis. Surg Case Rep. 2019;5:130.","journal-title":"Surg Case Rep"},{"key":"1069_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","volume":"68","author":"CG Moertel","year":"1991","unstructured":"Moertel CG, Kvols LK, O\u2019Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer. 1991;68:227\u201332.","journal-title":"Cancer"},{"key":"1069_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","volume":"81","author":"E Mitry","year":"1999","unstructured":"Mitry E, Baudin E, Ducreux M, Sabourin JC, Rufi\u00e9 P, Aparicio T, et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer. 1999;81:1351\u20135.","journal-title":"Br J Cancer"},{"key":"1069_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/cas.12473","volume":"105","author":"T Yamaguchi","year":"2014","unstructured":"Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, et al. Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Cancer Sci. 2014;105:1176\u201381.","journal-title":"Cancer Sci"},{"key":"1069_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol. 2013;24:152\u201360.","journal-title":"Ann Oncol"},{"key":"1069_CR22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3109\/0284186X.2014.941999","volume":"53","author":"ET Janson","year":"2014","unstructured":"Janson ET, Sorbye H, Welin S, Federspiel B, Gr\u00f8nb\u00e6k H, Hellman P, et al. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncol. 2014;53:1284\u201397.","journal-title":"Acta Oncol"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-01069-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-020-01069-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-020-01069-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T12:00:25Z","timestamp":1607515225000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-020-01069-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1186\/s40792-020-01069-4","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"2 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patient has provided permission to publish these features of her case, and her identity has been protected.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has provided permission to publish these features of her case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}